<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339518</url>
  </required_header>
  <id_info>
    <org_study_id>1306056017</org_study_id>
    <nct_id>NCT03339518</nct_id>
  </id_info>
  <brief_title>Breast Cancer Recurrence Risk Counseling</brief_title>
  <acronym>BRIM3</acronym>
  <official_title>BRIM3: Breast Cancer Recurrence Risk Informational Materials Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Virginia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kentucky</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>West Virginia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of breast cancer survivors is growing. Women with a personal history of breast
      cancer worry about their risk of getting cancer again. The current study will develop
      counseling about breast cancer recurrence risk and will also get an estimate of the
      preliminary impact of this counseling. The goal is to enable women to make better decisions
      about their treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparative Perceived Risk of Breast Cancer</measure>
    <time_frame>6 months</time_frame>
    <description>Comparative perceived risk will be assessed with a comparative risk item (i.e., compared those of the same gender and race; Lipkus, CEBP 2000).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute Perceived Risk of Breast Cancer</measure>
    <time_frame>6 months</time_frame>
    <description>Absolute perceived risk will be assessed with an absolute risk item to assess risk as a percentage (Kelly, PONC, 2005).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>BRIM3 Educational intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals will receive a booklet and counseling about risk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait list Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At the completion of the study, individuals in the wait list condition will receive a booklet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>BRIM3 educational intervention</intervention_name>
    <description>Breast Cancer risk education and counseling</description>
    <arm_group_label>BRIM3 Educational intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Wait List</intervention_name>
    <description>Booklet at the end of study</description>
    <arm_group_label>Wait list Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who (1) have a personal history of a single stage 0-2 breast cancer, (2) were
             recently diagnosed within the past 6 months, and (3) are treated at a participating
             breast oncology clinic.

        Exclusion Criteria:

          -  Women who are unable to read/write in English.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly Kelly, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>304-293-1453</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Kelly, PhD</last_name>
    <phone>304-293-1453</phone>
    <email>kmkelly@hsc.wvu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghan Johnson, MPH</last_name>
      <phone>859-323-4540</phone>
      <email>mfjohnson14@uky.edu</email>
    </contact>
    <investigator>
      <last_name>Jamie Studts, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly M Kelly, PhD</last_name>
      <phone>304-293-1453</phone>
      <email>kmkelly@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Kimberly Kelly, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Virginia University</investigator_affiliation>
    <investigator_full_name>Kimberly Kelly</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>De-identified data will be available upon written request is appropriate human subjects protections are in place, and the request does not conflict with the aims of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

